ALVO vs INIS vs GRML Stock Comparison

Alvotech, Radnostix and Greenland Mines Prices as of Oct 26, 2026 Peers: Industry group
ALVO Alvotech
$4.62 -19.7% 1M -45.0% 1Y
Market cap
$1.44B
P/E
–
Revenue (TTM)
$105.94M
Div. yield
–
Generic Drugs Healthcare
2 wins
INIS Radnostix Inc
$0.05 -16.7% 1M 0.0% 1Y
Market cap
$26.46M
P/E
–
Revenue (TTM)
$11.23M
Div. yield
–
Generic Drugs Healthcare
5 wins
GRML Greenland Mines Ltd
$5.79 -60.5% 1M +929.2% 1Y
Market cap
$14.65M
P/E
–
Revenue (TTM)
—
Div. yield
–
Generic Drugs Healthcare
1 win

Head to Head

8 decided of 12

Radnostix leads on 5 of the 12 questions below (Radnostix 5, Alvotech 2, Greenland Mines 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionALVOINISGRMLLeader
Larger companyMarket capitalisation $1.44B $26.46M $14.65M ALVO
Cheaper on earningsLower P/E, profitable companies only -5.1x -9.2x -0.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months -74.3% -23.7% — INIS
More profitableNet margin, trailing twelve months -248.0% -25.5% — INIS
Better return on capitalReturn on invested capital 4.4% — — –
Less leveragedLower net debt / EBITDA 13.1x -0.5x — INIS
Higher dividend yieldTrailing dividend yield — — — –
Better 1-year returnPrice return, last 12 months -45.0% 0.0% +929.2% GRML
Better 5-year returnAnnualised price return, 5 years -14.1%/yr -13.0%/yr — INIS
Less volatileAnnualised volatility, 1 year 81.8% 169.2% 445.7% ALVO
Higher overall scoreMean of the five percentile scores vs peers 51/100 52/100 35/100 INIS

Percentile Scorecard

ALVOINISGRML

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisALVOINISGRML
Valuation 76 #67 of 275 84 #46 of 275 14 #236 of 275
Growth 35 #166 of 253 4 #244 of 253 3 #245 of 253
Profitability 68 #73 of 224 71 #65 of 224 71 #66 of 224
Financial Health 25 #223 of 296 20 #236 of 296 79 #64 of 296
Shareholder Returns – 81 #25 of 126 9 #115 of 126
Overall 51 52 35
  • ALVO ranked among 305 companies in Pharmaceuticals and Biotechnology
  • INIS ranked among 305 companies in Pharmaceuticals and Biotechnology
  • GRML ranked among 305 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodALVOINISGRMLSPY
1 month -19.7%-16.7%-60.5% -0.8%
3 months +50.0%-28.6%+2,947.4% +3.5%
6 months +40.0%-37.5%+1,129.8% +7.0%
Year to date -9.9%-16.7%+1,903.5% +12.2%
1 year -45.0%0.0%+929.2% +13.0%
3 years -48.6%0.0%-45.8% +86.3%
3 years, per year -19.9%0.0%-18.5% +23.1%
5 years -53.3%-50.0%— +68.6%
5 years, per year -14.1%-13.0%— +11.0%
10 years —-37.5%— +258.0%
10 years, per year —-4.6%— +13.6%

Risk

MeasureALVOINISGRMLSPY
Volatility, 1Y 81.8%169.2%445.7% 12.7%
Downside volatility, 1Y 86.1%264.0%158.9% 12.7%
Beta vs S&P 500, 1Y 0.732.052.77 1.00
Return / volatility, 1Y -0.550.002.08 1.02
Max drawdown, 5Y -82.6%-70.0%-99.0% -25.4%
From 52-week high -43.2%-54.5%-61.1% -1.8%
52-week high $8.13$0.11$14.89 $779.14
52-week low $3.00$0.04$0.17 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleALVOINISGRML
P/E now vs peer median -5.1xmedian 10.4x -9.2xmedian 10.4x -0.7xmedian 10.4x
P/S now vs peer median 13.6xmedian 6.4x 2.4xmedian 6.4x —median 6.4x
EV/EBITDA now vs peer median 29.3xmedian 10.7x -11.0xmedian 10.7x —median 10.7x
P/FCF now vs peer median -5.5xmedian 12.5x -28.6xmedian 12.5x -1.0xmedian 12.5x
P/B now vs peer median -7.5xmedian 1.6x 14.0xmedian 1.6x 0.3xmedian 1.6x
PEG now vs peer median -0.21median 0.29 0.25median 0.29 0.01median 0.29

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsALVOINISGRML
Revenue $105.94M $11.23M –
Gross profit $7.66M $6.04M –
Operating income $47.54M -$2.90M -$18.67M
Net income -$179.60M -$2.86M -$21.77M
Free cash flow -$261.39M -$925.24K -$14.22M
R&D $46.37M $490.38K $1.28M
EPS (diluted) $-0.90 $-0.01 $-8.60
Cash & equivalents $142.80M $1.20M $9.34M
Total debt $1.31B $8.26M $2.07M
Shares (diluted) 291.34M 529.12M 2.53M
Enterprise value $1.01B $20.57M -$19.22M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricALVOINISGRML
P/E -5.1x -9.2x -0.7x
P/FCF -5.5x -28.6x -1.0x
P/Operating cash flow -7.3x -70.3x -1.0x
P/S 13.6x 2.4x –
P/B -7.5x 14.0x 0.3x
P/Tangible book -4.3x -21.4x 1.6x
EV/EBITDA 29.3x -11.0x –
EV/EBIT 54.8x -9.5x -0.3x
EV/Revenue 24.6x 2.5x –
EV/FCF -10.0x -29.8x -0.4x
EV/Operating cash flow -13.1x -73.3x -0.4x
PEG (3Y EPS CAGR) -0.21 0.25 0.01

Growth

14 metrics
MetricALVOINISGRML
Revenue growth (1Y) -74.3% -23.7% –
Revenue CAGR (3Y) 104.2% -2.6% –
Gross profit growth (1Y) -95.0% -32.4% –
Gross profit CAGR (3Y) 27.6% -4.0% –
Operating income growth (1Y) -13.3% -1,245% -127.6%
Operating income CAGR (3Y) 28.9% -50.5% -166.2%
Net income growth (1Y) -383.6% -2,437% -91.7%
Net income CAGR (3Y) 24.4% -38.0% -125.4%
EPS growth (1Y) -481.6% -2,429% 48.6%
EPS CAGR (3Y) 24.6% -37.0% -48.2%
Operating cash flow growth (1Y) -367.1% -157.0% -158.2%
Operating cash flow CAGR (3Y) 12.8% -41.4% -236.9%
Free cash flow growth (1Y) -113.0% -2,469% -158.2%
Free cash flow CAGR (3Y) 8.6% -69.5% -236.9%

Profitability

14 metrics
MetricALVOINISGRML
Gross margin 7.2% 53.8% –
EBITDA margin 83.9% -22.3% –
Operating margin 44.9% -25.8% –
Pretax margin -62.1% -28.3% –
Net margin -248.0% -25.5% –
FCF margin -246.7% -8.2% –
Operating cash flow margin -187.6% -3.4% –
Return on equity – -140.0% -39.8%
Return on assets -17.5% -18.8% -34.9%
Return on invested capital 4.4% – –
Return on capital employed 4.1% -22.8% -30.5%
Asset turnover 0.1x 0.7x –
Cash conversion (OCF / net income) 1.1x 0.1x 0.7x
Stock comp / revenue 8.7% 3.7% –

Financial Health

11 metrics
MetricALVOINISGRML
Debt / assets 82.3% 14.0% 0.5%
Debt / equity -6.8x 1.2x 0.0x
Net debt / EBITDA 13.1x -0.5x –
Debt / FCF -5.0x -2.5x 0.0x
Liabilities / assets 112.1% 88.6% 10.9%
Equity / assets -12.1% 11.4% 89.1%
Interest coverage 0.8x -8.5x -2,872x
Current ratio 1.6x 0.8x 10.1x
Quick ratio 1.1x 0.6x 7.7x
Cash ratio 0.4x 0.3x 7.7x
Altman Z-score -1.37 -9.85 –

Shareholder Returns

7 metrics
MetricALVOINISGRML
Dividend yield – – –
Net buyback yield – -0.1% -49.5%
Shareholder yield – -0.1% -49.5%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusALVOINISGRML
EPS, next fiscal year $-0.02FY2026 – –
Revenue, next fiscal year $588.58MFY2026 – –
Revenue growth, next FY -0.8%FY2026 – –
Revenue growth, the year after +22.3% – –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersALVOINISGRML
Held by institutions 14.7% – 12.0%
Institutions holding 72 – 47
Change in shares held, QoQ +152.4% – +96.3%
Institutions buying 44 – 34
Institutions selling 17 – 2
Buyers to sellers 2.59 – 17.00

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ALVOINISGRML
ALVO 1.00 -0.09 0.21
INIS -0.09 1.00 -0.05
GRML 0.21 -0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ALVO, INIS and GRML?

Alvotech (ALVO) is the largest by market capitalisation: Alvotech (ALVO) $1.44B, Radnostix (INIS) $26.46M, Greenland Mines (GRML) $14.65M.

Which company is growing faster?

Radnostix (INIS) grew revenue fastest over the trailing twelve months: Alvotech (ALVO) -74.3%, Radnostix (INIS) -23.7%.

Which company is more profitable?

Radnostix (INIS) has the highest net margin (Alvotech (ALVO) -248.0%, Radnostix (INIS) -25.5%).

Which stock has performed better?

Over the past year Greenland Mines (GRML) returned the most: Alvotech (ALVO) -45.0%, Radnostix (INIS) 0.0%, Greenland Mines (GRML) +929.2%. Over five years, Radnostix (INIS) compounded fastest (Alvotech (ALVO) -14.1%/yr, Radnostix (INIS) -13.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Alvotech (ALVO) has been the steadiest (Alvotech (ALVO) 81.8%, Radnostix (INIS) 169.2%, Greenland Mines (GRML) 445.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ALVO, INIS and GRML?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Radnostix (INIS) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.